Recent MRSN Stock Price | MRSN Stock Predictions | |
$4.30 | +48.37% |
$6.38 |
Recent MRSN Analyst Ratings Breakdown, Making MRSN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 7 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 2 | 5 | 5 | 5 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 1 | 1 | 1 |
Average rating: | 1.44 | 2.56 | 2.56 | 2.56 |
For the MRSN stock predictions from the analysts covering Mersana Therapeutics Inc, we have collected all of the individual MRSN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering MRSN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MRSN stock predictions may vary widely, another useful metric to consider is the median MRSN stock prediction, which represents the price at which half of the analysts
made MRSN stock predictions that were higher and half made MRSN stock predictions that were lower. This makes for a different take on the MRSN stock predictions out there, as compared to average or mean.
And that median across all the individual MRSN stock predictions was: $6.5 as of 2024-03-27.
The very highest of the MRSN stock predictions for one year price target was $9.0, while the very lowest of the MRSN stock predictions in the analyst group was
$5.0 (with a standard deviation of $1.407). Get the latest Zacks research report on MRSN — FREE
Find out: MRSN next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
PWR Stock Predictions
MTN Stock Predictions
BKR Stock Predictions
CAE Stock Predictions
ECOL Stock Predictions
HTHT Stock Predictions
SMPL Stock Predictions
GNCA Stock Predictions
RF Stock Predictions
|
|
Strong Buy (3.56 out of 4) 64th percentile
(ranked higher than approx. 64% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |